Dr. Valentina Agostoni joined TVM in 2020.

Valentina has hands-on experience in preclinical drug development, from hit identification to IND-enabling studies. She worked six years as Preclinical Development Scientist for different pharmaceutical startups (Versantis, spin-off of the ETH Zurich and Mperia Therapeutics, spin-off of the University of Montreal).

Valentina received her PhD in Biopharmacy at the University of Paris-Saclay.

• 

  Principal,Montreal in TVM Capital

  Making investments to transform healthcare